LMAT

87.51

2.41% 2.06

Handel nachbörslich: 87.51

Lemaitre Vascular Inc (LMAT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$85.45

Offen:

$85.46

24-Stunden-Volumen:

218.28K

Relative Volume:

1.30

Marktkapitalisierung:

$1.98B

Einnahmen:

$213.03M

Nettoeinkommen (Verlust:

$41.32M

KGV:

47.82

EPS:

1.83

Netto-Cashflow:

$33.49M

1W Leistung:

-2.63%

1M Leistung:

-8.24%

6M Leistung:

+4.30%

1J Leistung:

-5.79%

1-Tages-Spanne:

$84.44

$88.08

1-Wochen-Bereich:

$83.88

$90.02

52-Wochen-Spanne:

$71.42

$109.58

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Firmenname

Lemaitre Vascular Inc

Sektor

Healthcare (1147)

Branche

Medical Instruments & Supplies (58)

Telefon

781-221-2266

Adresse

63 SECOND AVENUE, BURLINGTON, MA

Mitarbeiter

664

Twitter

@LMAT_Vascular

Nächster Verdiensttermin

2025-02-24

Neueste SEC-Einreichungen

LMAT's Discussions on Twitter

Vergleichen Sie LMAT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LMAT Lemaitre Vascular Inc	87.51	1.93B	213.03M	41.32M	33.49M	1.83
ISRG Intuitive Surgical Inc	447.23	157.45B	9.15B	2.63B	1.99B	7.17
BDX Becton Dickinson Co	187.17	52.74B	21.39B	1.61B	2.55B	5.56
RMD Resmed Inc	273.73	39.69B	5.15B	1.40B	1.65B	9.51
ALC Alcon Inc	74.51	36.64B	10.03B	1.07B	1.39B	2.17
WST West Pharmaceutical Services Inc	262.33	18.72B	2.96B	487.70M	344.00M	6.68

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-06	Hochstufung	Barrington Research	Mkt Perform → Outperform
2025-02-28	Herabstufung	Barrington Research	Outperform → Mkt Perform
2025-02-28	Herabstufung	Oppenheimer	Outperform → Perform
2025-02-13	Eingeleitet	Wells Fargo	Equal Weight
2024-10-15	Eingeleitet	Cantor Fitzgerald	Neutral
2024-08-02	Fortgesetzt	Lake Street	Buy
2024-05-31	Fortgesetzt	ROTH MKM	Buy
2024-04-26	Hochstufung	Stifel	Hold → Buy
2024-02-06	Fortgesetzt	KeyBanc Capital Markets	Sector Weight
2023-10-23	Eingeleitet	JMP Securities	Mkt Outperform
2023-09-06	Eingeleitet	Oppenheimer	Outperform
2023-08-03	Herabstufung	Jefferies	Buy → Hold
2023-05-03	Hochstufung	Barrington Research	Mkt Perform → Outperform
2022-10-28	Herabstufung	Barrington Research	Outperform → Mkt Perform
2021-09-16	Eingeleitet	Jefferies	Buy
2021-02-12	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-03-16	Hochstufung	Sidoti	Neutral → Buy
2019-10-24	Herabstufung	First Analysis Sec	Strong Buy → Outperform
2019-10-24	Hochstufung	Lake Street	Hold → Buy
2019-10-14	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2019-07-25	Bestätigt	Barrington Research	Outperform
2019-07-25	Hochstufung	First Analysis Sec	Neutral → Outperform
2018-10-08	Hochstufung	Barrington Research	Mkt Perform → Outperform
2018-10-08	Hochstufung	ROTH Capital	Neutral → Buy
2018-06-08	Fortgesetzt	ROTH Capital	Buy
2018-04-26	Herabstufung	Stifel	Buy → Hold
2018-04-26	Hochstufung	The Benchmark Company	Hold → Buy
2017-10-27	Herabstufung	First Analysis Sec	Overweight → Equal-Weight
2017-10-27	Herabstufung	The Benchmark Company	Buy → Hold
2017-07-10	Herabstufung	Canaccord Genuity	Buy → Hold
2017-07-10	Herabstufung	The Benchmark Company	Buy → Hold
2017-03-21	Eingeleitet	First Analysis Sec	Overweight
2017-02-22	Herabstufung	Barrington Research	Outperform → Mkt Perform
2016-09-22	Herabstufung	Sidoti	Buy → Neutral
2016-07-28	Bestätigt	Barrington Research	Outperform
2016-02-25	Bestätigt	Barrington Research	Outperform

Alle ansehen

Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten

Sep 30, 2025

How LeMaitre Vascular Inc. (LHU) stock reacts to Fed tighteningMarket Volume Report & Capital Efficient Trading Techniques - newser.com

Sep 30, 2025

What drives LeMaitre Vascular Inc stock priceVWAP Trading Strategies & Build Diversified Portfolios With Ease - earlytimes.in

Sep 30, 2025

What analysts say about LeMaitre Vascular Inc stockMarket Sentiment Report & Superior Trading Ideas - earlytimes.in

Sep 30, 2025

What MACD and RSI say about LeMaitre Vascular Inc.July 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com

Sep 30, 2025

Multi asset correlation models including LeMaitre Vascular Inc.July 2025 Levels & Low Drawdown Momentum Ideas - newser.com

Sep 30, 2025

Smart tools for monitoring LeMaitre Vascular Inc.’s price action2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com

Sep 30, 2025

LeMaitre Vascular Inc. stock chart pattern explainedTrade Analysis Report & Long-Term Safe Investment Plans - newser.com

Sep 30, 2025

Sep 29, 2025

Using R and stats models for LeMaitre Vascular Inc. forecasting2025 Year in Review & Growth Oriented Trade Recommendations - newser.com

Sep 29, 2025

Will a bounce in LeMaitre Vascular Inc. offer an exit2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com

Sep 29, 2025

Analyzing LeMaitre Vascular Inc. with risk reward ratio chartsJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com

Sep 29, 2025

Sep 28, 2025

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st

Sep 28, 2025

Sep 27, 2025

Congress Asset Management Co. Has $55.97 Million Position in LeMaitre Vascular, Inc. $LMAT - Defense World

Sep 27, 2025

Sep 25, 2025

Oversold Conditions For LeMaitre Vascular (LMAT) - Nasdaq

Sep 25, 2025

LeMaitre Vascular (NASDAQ:LMAT) Has A Rock Solid Balance Sheet - 富途牛牛

Sep 25, 2025

Sep 24, 2025

LeMaitre Vascular (NASDAQ:LMAT) Receives “Outperform” Rating from Barrington Research - Defense World

Sep 24, 2025

Sep 23, 2025

LeMaitre to Participate at Upcoming Investor Conferences in September - 富途牛牛

Sep 23, 2025

LeMaitre Vascular (NASDAQ:LMAT) Given Outperform Rating at Barrington Research - MarketBeat

Sep 23, 2025

Analyst Michael Petusky Maintains Outperform Rating on LMAT | LM - GuruFocus

Sep 23, 2025